Topic: Value of Medical Writing
Podcasts

The rapidly growing industry of regulatory medical writing calls for a 2025 prediction podcast! Listen up for “What’s Hot and What’s Not” from our experts Lisa Chamberlain James, Julia Forjanic Klapproth and Sonica Batra and get a glimpse of what Trilogy, an Indegene Company and Indegene will be up to this year.


Long time friends and industry colleagues, Lisa Chamberlain James with Trilogy and Cheryl Roberts with BioMarin Pharmaceutical sit down to discuss orphan drugs. They go over clinical trial hurdles, key incentives for health authorities, the medical writing process and start with an important question – why are orphan drugs called orphan drugs? Find out on episode 28 of TriloTalk!


In this episode, Julia and Lisa take a deep dive into General Medical Writing Principles. Join them as they navigate through a diverse range of topics that are crucial in the everyday practice of crafting clear and concise regulatory documents. Our hosts will generously share their personal insights, experiences, and invaluable tips that have positioned them as Masters in the field of medical writing. Happy podcasting!

Publications




